Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Townsend

Showing results (571-580 of 583) with videos related to

Pageof 59
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|May 3, 2021
Feeding intolerance in critically ill patients with COVID-19Rebecca Liu, Mary Paz, Layla Siraj, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled TrialDavid Isenberg, Richard Furie, Nicholas S Jones, et al.
Cell Reports. Medicine|July 25, 2023
An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseasesMarkus M Xie, Bingbing Dai, Jason A Hackney, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County StudyConstantine G Lyketsos, Leslie Toone, JoAnn Tschanz, et al.
Annals of the Rheumatic Diseases|March 18, 2019
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patientsFrances Humby, Myles Lewis, Nandhini Ramamoorthi, et al.
Journal of Medicinal Chemistry|October 24, 2022
Overcoming Preclinical Safety Obstacles to Discover (<i>S</i>)-<i>N</i>-((1,2,3,5,6,7-Hexahydro-<i>s</i>-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5<i>H</i>-pyrazolo[5,1-<i>b</i>][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 InhibitorChristopher McBride, Lynnie Trzoss, Davide Povero, et al.
JCI Insight|April 14, 2017
Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN<b>α</b>-driven lupus nephritisArna Katewa, Yugang Wang, Jason A Hackney, et al.
Cell Reports|August 29, 2019
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response PhenotypesMyles J Lewis, Michael R Barnes, Kevin Blighe, et al.
Cell Genomics|June 30, 2023
A systems biology approach uncovers novel disease mechanisms in age-related macular degenerationLuz D Orozco, Leah A Owen, Jeffrey Hofmann, et al.
Journal of Environmental Radioactivity|September 19, 2019
Migration of noble gas tracers at the site of an underground nuclear explosion at the Nevada National Security SiteC Johnson, C E Aalseth, T R Alexander, et al.
Pageof 59

Showing results (571-580 of 583) with videos related to

Sort By:
Pageof 59
Clinical Nutrition (Edinburgh, Scotland)|May 3, 2021
Feeding intolerance in critically ill patients with COVID-19Rebecca Liu, Mary Paz, Layla Siraj, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled TrialDavid Isenberg, Richard Furie, Nicholas S Jones, et al.
Cell Reports. Medicine|July 25, 2023
An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseasesMarkus M Xie, Bingbing Dai, Jason A Hackney, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County StudyConstantine G Lyketsos, Leslie Toone, JoAnn Tschanz, et al.
Annals of the Rheumatic Diseases|March 18, 2019
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patientsFrances Humby, Myles Lewis, Nandhini Ramamoorthi, et al.
Journal of Medicinal Chemistry|October 24, 2022
Overcoming Preclinical Safety Obstacles to Discover (<i>S</i>)-<i>N</i>-((1,2,3,5,6,7-Hexahydro-<i>s</i>-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5<i>H</i>-pyrazolo[5,1-<i>b</i>][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 InhibitorChristopher McBride, Lynnie Trzoss, Davide Povero, et al.
JCI Insight|April 14, 2017
Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN<b>α</b>-driven lupus nephritisArna Katewa, Yugang Wang, Jason A Hackney, et al.
Cell Reports|August 29, 2019
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response PhenotypesMyles J Lewis, Michael R Barnes, Kevin Blighe, et al.
Cell Genomics|June 30, 2023
A systems biology approach uncovers novel disease mechanisms in age-related macular degenerationLuz D Orozco, Leah A Owen, Jeffrey Hofmann, et al.
Journal of Environmental Radioactivity|September 19, 2019
Migration of noble gas tracers at the site of an underground nuclear explosion at the Nevada National Security SiteC Johnson, C E Aalseth, T R Alexander, et al.
Pageof 59